News, Analysis & Insights on Nutrition, Supplements, and Health
The first commercialised ingredient in the Nextida platform, a range of specific collagen peptide compositions with targeted health benefits, Nextida™ GC targets post-prandial glucose spikes, naturally, and is backed by science.
An initial proof-of-concept clinical study showed that a 5 or 10 gram dose of Nextida GC significantly reduced post-prandial glucose spikes in healthy individuals when taken orally 30 minutes before a meal. The reduction observed was 42% on average after a meal.
Paid for and content provided by Rousselot
With an aging population and changing ideas about what being ‘older’ means, the elderly nutrition market is booming. Learn how manufacturers can support mobility here.
An active lifestyle needs balanced nutrition. Carbohydrates provide energy but may cause energy spikes and crashes together with cravings and overeating.
Nextida™ GC, a specific collagen peptide composition, naturally targets post-prandial glucose spikes. Developed by Rousselot, it enhances GLP-1 hormone production, a key mechanism for maintaining balanced blood sugar.
For more product information visit Rousselot.